<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht001694.v2" study_id="phs000285.v3" participant_set="2" date_created="Tue Aug 20 16:11:53 2013"><variable id="phv00116360.v2"><name>Individual_ID</name><description>Subject Identifier</description><type>string</type></variable><variable id="phv00116361.v2"><name>CLEFACT7</name><description>FACTOR VII (%)</description><type>decimal</type><unit>%</unit><logical_min>29</logical_min><logical_max>441</logical_max></variable><variable id="phv00116362.v2"><name>CLEFACT8</name><description>FACTOR VIII (%)</description><type>decimal</type><unit>%</unit><logical_min>14</logical_min><logical_max>246</logical_max></variable><variable id="phv00116363.v2"><name>CLEFIBR</name><description>FIBRINOGEN (MG/DL)</description><type>integer</type><unit>MG/DL</unit><logical_min>63</logical_min><logical_max>659</logical_max></variable><variable id="phv00116364.v2"><name>CLEVWANT</name><description>VON WILLEBRAND ANTIGEN (%)</description><type>decimal</type><unit>%</unit><logical_min>21</logical_min><logical_max>432</logical_max></variable><variable id="phv00116365.v2"><name>CLEVWACT</name><description>VON WILLEBRAND ACTIVITY (%)</description><type>decimal</type><unit>%</unit><logical_min>10</logical_min><logical_max>343</logical_max></variable><variable id="phv00116366.v2"><name>CLEBTYPE</name><description>ABO BLOOD TYPE</description><type>string</type></variable><variable id="phv00116367.v2"><name>CLELEWIS</name><description>LEWIS BLOOD GROUP PHENOTYPE</description><type>string</type></variable></data_table>
